Moderna Plans Big R&D Cut As Profitability Guidance Pushed Out

FDA Pushes Back On mRNA-4157 Accelerated Approval

 
• By Alaric DeArment
  
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business